The Role of The Tumor Microbiome in Tumor Development and Its Treatment

Abstract

Commensal bacteria and other microorganisms that reside in the human body are closely associated with the development and treatment of cancers. Recently, tumor microbiome (TM) has been identified in a variety of cancers such as pancreatic, lung, and breast cancers. TM has different compositions in different tumors and has different effects on tumors. TM plays an important role in the formation of the tumor microenvironment, regulation of local immunity, and modification of tumor cell biology, and directly affects the efficacy of drug treatment for tumors. TM is expected to be a biomarker for tumors, and engineered tumor-targeting bacteria and anti-cancer microbial agents (GEN-001) have an important role in the treatment of tumors. This paper reviews the relevant studies on TM in recent years and describes its distribution in different tumors, its correlation with clinical features, its effect on local immunity, and the research directions of TM in tumor treatment.

Titanium complexes affectBacillus subtilisbiofilm formation

“…The antibiofilm activity of these Ti(IV) complexes that are non-toxic to mammalian (mice) cells in the concentrations used in this study, 25,26 marks them as potential drugs that may affect Gram positive biofilm formation in catheters and implants. Moreover, recent studies have unraveled the bacterial species that inhabit various cancer tumors 51,52 and others have even shown that biofilms and tumors colocalize. 53 It is particularly intriguing, therefore, to look more deeply into the effect of Ti(IV) complexes on cancer treatment in cases where biofilm colocalization with tumors affects carcinogenesis, 54 and additional studies are required to determine the full scope of their treatment potential.…”

Re-evaluating the melanoma TIL compartment and its unexpected spectrum of exhausted and functional T cells

“…Perturbations in the microbial ecosystem have been linked to immune evasion, carcinogenesis, and chronic inflammation and can affect the efficacy of cancer immunotherapies, including ICIs 45 . While most studies have focused on the gut microbiome and its connection to immune surveillance dysregulation; the interplay between cancer cells, immune cells, and microbiota is also relevant in the tumor microenvironment 46,47 . Notably, it was observed that numerous tumor types, including melanoma, have distinct microbial signatures.…”

Salvianolic acid B from Salvia miltiorrhiza bunge: A potential antitumor agent

“…The main cause of cancer development is the dysfunction of autophagy encoded by various genes, such as tumor suppressors, anti-apoptotic proteins, and growth factors, which allow unrestricted cell proliferation ( Chen et al, 2022a ; Shen et al, 2022 ). Patients with early-stage cancer are at risk of distant metastasis.…”